Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples

Liquid chromatography-tandem mass spectrometry was used to analyze plasma proteins of volunteers (control) and patients with glioblastoma multiform (GBM). A database search was pre-set with a variable post-translational modification (PTM): phosphorylation, acetylation or ubiquitination. There were n...

Descripción completa

Detalles Bibliográficos
Autores principales: Petushkova, Natalia A., Zgoda, Victor G., Pyatnitskiy, Mikhail A., Larina, Olesya V., Teryaeva, Nadezhda B., Potapov, Alexander A., Lisitsa, Andrey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426747/
https://www.ncbi.nlm.nih.gov/pubmed/28493947
http://dx.doi.org/10.1371/journal.pone.0177427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426747/
https://www.ncbi.nlm.nih.gov/pubmed/28493947
http://dx.doi.org/10.1371/journal.pone.0177427

Ejemplares similares